Celcuity (CELC) Change in Accured Expenses (2016 - 2025)
Celcuity (CELC) reported Change in Accured Expenses of $11.1 million for Q4 2025, up 320.93% on a YoY basis from $2.6 million in Q4 2024, and up 606.79% quarter-over-quarter from -$2.2 million in Q3 2025.
Celcuity (CELC) Change in Accured Expenses (2016 - 2025) Analysis & Trends
Celcuity has reported Change in Accured Expenses for 10 years, with the latest figure at $11.1 million in Q4 2025.
- For the quarter ending Q4 2025, Change in Accured Expenses rose 320.93% year-over-year to $11.1 million; the trailing twelve-month figure through Dec 2025 stood at $15.4 million (up 410.72% YoY), and the FY2025 full-year result was $15.4 million, up 410.72% from the prior year.
- Change in Accured Expenses for Q4 2025 stood at $11.1 million, up from -$2.2 million in the prior quarter.
- The five-year high for Change in Accured Expenses was $11.1 million in Q4 2025, with the low at -$5.0 million in Q4 2024.
- Historically, Change in Accured Expenses has averaged $1.3 million across 5 years, with a median of $731978.5 in 2023.
- Annual changes were most pronounced in 2021 — Change in Accured Expenses sank 533.84% — and 2022, when it surged 4232.71%.
- Celcuity's Change in Accured Expenses stood at -$76959.0 in 2021, then soared by 1382.46% to $986965.0 in 2022, then surged by 106.69% to $2.0 million in 2023, then plunged by 346.82% to -$5.0 million in 2024, then soared by 320.93% to $11.1 million in 2025.
- The last three Change in Accured Expenses figures came in at $11.1 million (Q4 2025), -$2.2 million (Q3 2025), and $5.8 million (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change Accured Exp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - | - |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - | - |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - | 931,000.00 |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - | - |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - | 644,700.00 |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn | 70.50 Mn |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - | - |
| 10 | Celcuity | 4.14 Bn | 3.42 Bn | - | 11.12 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 11.12 Mn |
| Dec 31, 2025 | 11.12 Mn |
| Sep 30, 2025 | -2.20 Mn |
| Sep 30, 2025 | -2.20 Mn |
| Jun 30, 2025 | 5.83 Mn |
| Jun 30, 2025 | 5.83 Mn |
| Mar 31, 2025 | 633,000.00 |
| Mar 31, 2025 | 633,000.00 |
| Dec 31, 2024 | -5.04 Mn |
| Dec 31, 2024 | -5.04 Mn |
| Sep 30, 2024 | 3.83 Mn |
| Sep 30, 2024 | 3.83 Mn |
| Jun 30, 2024 | 1.92 Mn |
| Jun 30, 2024 | 1.92 Mn |
| Mar 31, 2024 | 2.30 Mn |
| Mar 31, 2024 | 2.30 Mn |
| Dec 31, 2023 | 2.04 Mn |
| Dec 31, 2023 | 2.04 Mn |
| Sep 30, 2023 | 3.02 Mn |
| Sep 30, 2023 | 3.02 Mn |